Workflow
IT
icon
搜索文档
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE's Ongoing Ovarian and Colorectal Cancer Trials
Globenewswire· 2025-07-09 20:05
Article Indicates that Inhibition of PP2A Enhances Immunotherapy Responsewith LIXTE’s Proprietary Compound LB100 PASADENA, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the medical journal Nature has published findings by a team of physician-scientists that validate LIXTE’s ongoing clinical trials with its proprietary compound LB100 for Ovarian and Colorectal canc ...
Despite 2 Scary Words - Bitcoin And Diversification, I'm A Riot Platforms Fan
Seeking Alpha· 2025-07-09 20:00
After 43+ years working for one investment research company or another, I finally retired. So now, I’m completely independent. And for the first time on Seeking Alpha, I won’t be working based on anybody else’s product agenda. I have only one goal now… to give you the best actionable investment insights I can.I have long specialized in rules/factor-based equity investing strategies. But I’m different from others who share such backgrounds. I don’t serve the numbers. Instead, the numbers serve me… to inspire ...
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
Globenewswire· 2025-07-09 20:00
WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced Randi Isaacs, M.D., Chief Medical Officer, will speak at the upcoming KidneyCAN 7th Annual Kidney Cancer Research Summit taking place July 17-18 in ...
zSpace Imagine Wins Future's Best of Show Award at ISTELive25, Presented by Tech & Learning
Globenewswire· 2025-07-09 20:00
文章核心观点 - zSpace公司的zSpace Imagine获2025年ISTE展会未来最佳展示奖,连续两年获此殊荣,体现其在教育领域提供变革性沉浸式技术的承诺 [1] 获奖情况 - zSpace Imagine在小学教育类别获Tech & Learning颁发的未来最佳展示奖,这是公司连续第二年在ISTE展会获此奖,2024年获奖的是创新职业准备解决方案 [1] - 奖项由行业专家评委和编辑评估,根据创新、功能集、可靠性和性能等标准打分评选,获奖者在ISTELive25的Tech & Learning招待会上公布并在techlearning.com发布新闻稿 [2] zSpace Imagine产品介绍 - zSpace Imagine是首款专为小学教育打造的增强和虚拟现实笔记本电脑,无需头戴设备即可提供沉浸式互动学习体验,通过支持触控笔的无眼镜3D显示屏,让中小学生以实践、有趣的方式探索STEM、CTE和核心科目 [3] 各方评价 - 奖项编辑团队称最佳展示奖提名产品展示了展会新技术,凸显了改变全球学校教育的产品和企业 [4] - zSpace首席执行官表示获此奖体现公司为学生打造适龄沉浸式学习工具的使命,Imagine让学校以吸引、有效且易获取的方式引入AR/VR技术 [5] zSpace公司介绍 - zSpace提供创新的增强和虚拟现实体验,推动STEM、CTE和职业准备项目发展,受超3500个学区、技术中心、社区学院和大学信赖 [5] - 公司总部位于加州圣何塞,拥有超70项专利,“边做边学”解决方案被证明可增强学习过程、提高学生考试成绩 [5]
RBC Capital raises Tesla stock price target
Finbold· 2025-07-09 19:41
RBC Capital has raised its Tesla (NASDAQ: TSLA) stock price target from $307 to $319, maintaining its Outperform rating.Elaborating on his confidence in the stock, analyst Tom Narayan noted that the electric vehicle (EV) company met analyst expectations in regard to the number of cars delivered in Q2, while allso beating the industry’s quarterly energy storage sales averages:“Tesla reported 384K in Q2/25 deliveries, in line with company-polled consensus. It also did 9.6 GWh of energy storage sales in the qu ...
NextGen Digital Announces Private Placement of Special Warrants Convertible into Secured Digital Asset-Backed Notes
Globenewswire· 2025-07-09 19:30
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, B.C., July 09, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has entered into a term sheet with an arm’s-length purchaser (the “Purchaser”) providing for a non-brokered private placement (the “Offering”) of up to 2,000 special warrants of the Company (the “Special Warrants”) for gross proceeds of up ...
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
Globenewswire· 2025-07-09 19:30
REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that the abstract titled “Preliminary Patient Demographics And Baseline Characteristics From A Phase 3 Study (sunRIZE) Of Ersodetug For Hypoglycemia Due To Congenital Hyperinsulinism: Trial In Progress” has been selected for a late-breaking presentation at ENDO 2025 taking place ...
Theratechnologies Reports Financial Results for the Second Quarter 2025
Globenewswire· 2025-07-09 19:30
Q2 2025 total revenue of $17.7 million, and $36.8 million for the first six months of Fiscal 2025Positive Adjusted EBITDA1 for the fifth straight quarterSubsequent to quarter end, Theratechnologies entered into a definitive agreement to be acquired by an affiliate of Future Pak MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial result ...
Gilat Awarded Over $22 Million in Orders from Tier One Satellite Operators
Globenewswire· 2025-07-09 19:04
Operator demand fuels Gilat’s momentum across GEO, MEO, and LEO VHTS constellationsPETAH TIKVA, Israel, July 09, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that its Commercial Division has received over $22 million in orders from leading satellite operators around the world. The orders are scheduled for delivery over the next 12 months. These new orders reflect Gilat’s growi ...
Akamai Technologies To Hold Second Quarter 2025 Investor Conference Call On Thursday, August 7, at 4:30 PM ET
Prnewswire· 2025-07-09 19:01
CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers business online, announced today that the company will hold a conference call for investors on Thursday, August 7, 2025, at 4:30 p.m. ET. The call will include the company's second quarter 2025 financial results and may include forward-looking financial guidance from management. The call will also be broadcast live via the internet at Akamai's Investor Relations  ...